Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Low-dose endotoxin potentiates capsaicin-induced pain in man: evidence for a pain neuroimmune connection|
|Citation:||Brain, Behavior, and Immunity, 2013; 30:3-11|
|Publisher:||Academic Press Inc|
|Mark R. Hutchinson, Mara Buijs, Jonathan Tuke, Yuen Hei Kwok, Melanie Gentgall, Desmond Williams, Paul Rolan|
|Abstract:||Despite the wealth of evidence in animals that immune activation has a key role in the development and maintenance of chronic pain, evidence to support this in humans is scant. We have sought such evidence by examining the effect of a subtle immunological stimulus, low dose intravenous endotoxin, on the allodynia, hyperalgesia, flare and pain produced by intradermal capsaicin in healthy volunteers. Here we provide evidence of immune priming of this neuropathic-like pain response in humans. Specifically, in 12 healthy volunteers, activation of Toll-Like Receptor 4 by endotoxin (0.4ng/kg IV) caused significant 5.1-fold increase in the 90-min integral of areas of capsaicin-induced allodynia (95% CI 1.3-9.1), 2.2-fold increase in flare (95% CI 1.9-2.6) and 1.8-fold increase in hyperalgesia (95% CI 1.1-2.5) following 50μg intradermal capsaicin injected into the forearm 3.5h after endotoxin. These data demonstrate clinically a significant role for the neuroimmune pain connection in modifying pain, thus providing evidence that immune priming may produce pain enhancement in humans and hence offer a novel range of pharmacological targets for anti-allodynics and/or analgesics. Additionally, the simplicity of the model makes it suitable as a test-bed for novel immune-targeted pain therapeutics.|
|Rights:||Copyright © 2013 Elsevier Inc. All rights reserved.|
|Appears in Collections:||Aurora harvest|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.